Three Monash BDI researchers among world’s most highly cited scientists
Three Monash Biomedicine Discovery Institute (BDI) researchers have each been ranked as a 2022 Highly Cited Researcher in the list released by Clarivate Analytics. The annual list identifies the 1 in 1,000 scientists and social scientists of the world’s population, who have published the highest number of peer-reviewed scientific papers cited by other researchers.
Professor Jamie Rossjohn, Professor Jian Li and Professor Charles Mackay have been recognised for their exceptional research performance in their respective fields, determined by production of multiple highly cited papers that rank in the top one per cent by citations for a field and year in the Web of Science.
Professor Rossjohn’s research focus is on understanding, at the molecular level, how the T cell receptor specifically recognises polymorphic Human Leukocyte Antigen (HLA) molecules in the context of protective immunity, autoimmunity and other adverse T cell reactivities. Further, he has pioneered the molecular understanding of lipid and metabolite-based immunity by T cells that recognise HLA class-I like molecules, CD1 and MR1, respectively. This is the fifth consecutive year that Professor Rossjohn has appeared on the Clarivate Analytics Highly Cited Researcher list.
Professor Li has been working on the pharmacology of polymyxins, a major class of antibiotics against Gram-negative ‘superbugs’, and the discovery and development of new antibiotics. His team has discovered a new antibiotic drug QPX9003 from concept to clinical trials. He has established a comprehensive antimicrobial discovery platform with teams from medicinal chemistry to in vivo pharmacology, resulting in successful international industry collaborations. His research has also led to the first scientifically-based dosing guidelines for polymyxins and improved clinical practice worldwide. Professor Li appeared on the Clarivate Analytics Highly Cited Researcher list from 2015 to 2017.
Professor Mackay has forged a new understanding of the gut microbiome and the important role it plays in immune responses including allergies and in a number of diseases including type 1 diabetes. His research into how immune responses can be manipulated using 'medicinal foods', as well as novel gut microbial species, is attracting both clinical and public interest, with the latest research findings moving to clinical trials. Professor Mackay was highly cited from 2005 to 2010 under what was then the Institute for Scientific Information citation, and has remained on the Clarivate Analytics Highly Cited Researcher list since 2017.
A total of 20 Monash University researchers have been names as the world’s most influential academics in their fields as part of Clarivate’s list of Highly Cited Researchers for 2022. To see the full list of researchers, read the Monash article.
About the Monash Biomedicine Discovery Institute
Committed to making the discoveries that will relieve the future burden of disease, the Monash Biomedicine Discovery Institute (BDI) at Monash University brings together more than 120 internationally-renowned research teams. Spanning seven discovery programs across Cancer, Cardiovascular Disease, Development and Stem Cells, Infection, Immunity, Metabolism, Diabetes and Obesity, and Neuroscience, Monash BDI is one of the largest biomedical research institutes in Australia. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.